R. H. van den Berg

发表

The first subcomponent of complement, C1q, triggers the production of IL-8, IL-6, and monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells.

Robert B Sim, M. Daha, M. Faber-Krol, 1998, Journal of immunology.

Inhibition of activation of the classical pathway of complement by human neutrophil defensins.

M. Daha, P. Hiemstra, S. van Wetering, 1998, Blood.

Defective MHC class II expression in an MHC class II deficiency patient is caused by a novel deletion of a splice donor site in the MHC class II transactivator gene

P. J. van den Elsen, A. Peijnenburg, Ö. Sanal, 2000, Immunogenetics.

Inhibition of the hemolytic activity of the first component of complement C1 by an Escherichia coli C1q binding protein.

M. Daha, L. van Es, J. A. van de Klundert, 1996, Journal of immunology.

The RFX complex is crucial for the constitutive and CIITA-mediated transactivation of MHC class I and beta2-microglobulin genes.

P. J. van den Elsen, A. Peijnenburg, M. Eggermond, 1998, Immunity.

Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene

P. J. van den Elsen, A. Peijnenburg, Ö. Sanal, 1999, Immunogenetics.

Discoordinate expression of invariant chain and MHC class II genes in class II transactivator-transfected fibroblasts defective for RFX5.

P. J. van den Elsen, A. Peijnenburg, J. Vossen, 1999, Journal of immunology.

Intracellular localization of the human receptor for the globular domains of C1q.

M. Daha, L. van Es, F. Prins, 1997, Journal of immunology.